Compare FNF & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FNF | PEN |
|---|---|---|
| Founded | 1847 | 2004 |
| Country | United States | United States |
| Employees | 24535 | N/A |
| Industry | Specialty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 12.8B |
| IPO Year | 2005 | 2015 |
| Metric | FNF | PEN |
|---|---|---|
| Price | $49.43 | $327.26 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 16 |
| Target Price | $60.50 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 1.5M | 441.5K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.98% | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | ★ 0.90 | 0.82 |
| Revenue | ★ $14,445,000,000.00 | $1,403,665,000.00 |
| Revenue This Year | $10.90 | $14.34 |
| Revenue Next Year | $5.44 | $13.71 |
| P/E Ratio | ★ $54.56 | $399.38 |
| Revenue Growth | 5.58 | ★ 17.50 |
| 52 Week Low | $42.78 | $221.26 |
| 52 Week High | $61.40 | $362.41 |
| Indicator | FNF | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 50.34 | 52.10 |
| Support Level | $46.67 | $326.58 |
| Resistance Level | $60.63 | $335.61 |
| Average True Range (ATR) | 1.46 | 2.23 |
| MACD | -0.16 | 0.76 |
| Stochastic Oscillator | 49.31 | 87.19 |
Fidelity National Financial Inc is a provider of (i) title insurance, escrow and other title-related services, including trust activities, trustee sales guarantees, recordings and reconveyances and home warranty and (ii) transaction services to the real estate and mortgage industries. It operates in three segments: Title, F&G, Corporate and Other. The title segment that derives the majority of revenue consists of the operations of title insurance underwriters and related businesses, which provide title insurance and escrow and other title-related services including trust activities, trustee sales guarantees, and home warranty products. All of the company's revenue is generated in the United States.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.